Guangzhou Doublle Bioproduct Co Announces Clinical Update and Partner Search for Adenolysin for Head and Neck Cancer
Guangzhou Doublle Bioproduct gives a clinical and commercial update on its Adenolysin gene therapy asset for head and neck cancer as its seeks global partners
Source: einnews.com